German Pharmaceuticals & Biotech Potentially Undervalued Companies

Valneva

Market Cap: €721.3m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

Daiichi Sankyo Company

Market Cap: €6.5t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

Ono Pharmaceutical

Market Cap: €803.3b

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

Swedish Orphan Biovitrum

Market Cap: €95.3b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

China Medical System Holdings

Market Cap: €36.4b

An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.

Dynavax Technologies

Market Cap: €1.1b

A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.

China Resources Pharmaceutical Group

Market Cap: €31.2b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

Heron Therapeutics

Market Cap: €227.3m

A commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.

GNI Group

Market Cap: €138.8b

Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.

Verano Holdings

Market Cap: €550.0m

Operates as a vertically integrated multi-state cannabis operator in the United States.

Evotec

Market Cap: €1.1b

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

MPH Health Care

Market Cap: €79.8m

An investment company, engages in the healthcare business in Germany.

Jilin Province Huinan Changlong Bio-pharmacy

Market Cap: €1.2b

Manufactures and distributes Chinese medicines and pharmaceutical products in the People’s Republic of China.

Saniona

Market Cap: €1.6b

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.

Abera Bioscience

Market Cap: €122.8m

A platform and vaccine development company, research, design, and develops vaccines and immunotherapies based on its proprietary vaccine delivery platform in Sweden and internationally.

UroGen Pharma

Market Cap: €836.0m

Engages in the development and commercialization of solutions for urothelial and specialty cancers.

Xencor

Market Cap: €614.8m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibodies for the treatment of asthma and allergic diseases, autoimmune diseases, and cancer.

Actinium Pharmaceuticals

Market Cap: €51.8m

Develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies.

Novartis

Market Cap: €187.0b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

ANI Pharmaceuticals

Market Cap: €1.9b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

Zai Lab

Market Cap: €3.6b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

Takara Bio

Market Cap: €115.8b

Engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally.

BioCryst Pharmaceuticals

Market Cap: €1.6b

A biotechnology company, develops oral small-molecule and injectable protein therapeutics to treat rare diseases.

Pacira BioSciences

Market Cap: €1.2b

Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.

Abeona Therapeutics

Market Cap: €291.3m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

Gerresheimer

Market Cap: €1.5b

Provides medicine packaging, drug delivery devices, and solutions in Germany and internationally.

Laboratorios Farmaceuticos Rovi

Market Cap: €3.0b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Iovance Biotherapeutics

Market Cap: €832.3m

A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States.

Sprint Bioscience

Market Cap: €62.0m

A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.

Sanai Health Industry Group

Market Cap: €67.3m

An investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, and Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.

Hansoh Pharmaceutical Group

Market Cap: €219.1b

An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.

Qiagen

Market Cap: €9.9b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Mesa Laboratories

Market Cap: €357.4m

Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.

Evotec

Market Cap: €1.1b

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

Clinuvel Pharmaceuticals

Market Cap: €593.5m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

HUTCHMED (China)

Market Cap: €2.2b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.